BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26206732)

  • 21. Initial outcomes analysis for large multicenter integrated cancer network implementation of intensity modulated radiation therapy for breast cancer.
    Bhatnagar AK; Beriwal S; Heron DE; Flickinger JC; Deutsch M; Huq MS; Sontag M; Shogan J
    Breast J; 2009; 15(5):468-74. PubMed ID: 19624420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up.
    Raiyawa T; Lertbutsayanukul C; Rojpornpradit P
    J Med Assoc Thai; 2009 Mar; 92(3):390-7. PubMed ID: 19301734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
    Guenzi M; Vagge S; Azinwi NC; D'Alonzo A; Belgioia L; Garelli S; Gusinu M; Corvò R
    Radiat Oncol; 2010 Nov; 5():111. PubMed ID: 21092219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS).
    Kraus-Tiefenbacher U; Sfintizky A; Welzel G; Simeonova A; Sperk E; Siebenlist K; Mai S; Wenz F
    Radiat Oncol; 2012 Dec; 7():217. PubMed ID: 23249653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients.
    Bao YQ; Yu TH; Huang W; Mao QF; Tu GJ; Li B; Yi A; Li JG; Rao J; Zhang HW; Jiang CL
    Breast Cancer; 2024 May; ():. PubMed ID: 38705942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
    Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
    Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prone breast intensity modulated radiation therapy: 5-year results.
    Osa EO; DeWyngaert K; Roses D; Speyer J; Guth A; Axelrod D; Fenton Kerimian M; Goldberg JD; Formenti SC
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):899-906. PubMed ID: 24867535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer].
    Bayerl A; Frank D; Lenz A; Höss C; Lukas P; Feldmann HJ; Molls M
    Strahlenther Onkol; 2001 Jan; 177(1):25-32. PubMed ID: 11200109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late skin and subcutaneous soft tissue changes after 10-gy boost for breast conserving therapy.
    Okumura S; Mitsumori M; Kokubo M; Yamauchi C; Kawamura S; Oya N; Nagata Y; Hiraoka M
    Breast Cancer; 2003; 10(2):129-33. PubMed ID: 12736565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cosmetic results of breast conserving therapy for breast carcinoma. Treatment results from the Heidelberg Radiation Clinic in the years 1984 to 1992].
    Maessen D; Flentje M; Weischedel U
    Strahlenther Onkol; 1998 May; 174(5):251-6. PubMed ID: 9614953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMRT with the use of simultaneous integrated boost in treatment of head and neck cancer: acute toxicity evaluation.
    Vosmik M; Odrázka K; Dolezel M; Vaculíková M; Kordac P; Zouhar M; Petera J; Jansa J; Zoul Z; Paluska P; Vokurka J
    Acta Medica (Hradec Kralove); 2006; 49(3):167-73. PubMed ID: 17117605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose-rate brachytherapy for early breast cancer: an ambulatory technique.
    Hennequin C; Durdux C; Espié M; Balla-Mekias S; Housset M; Marty M; Chotin G; Maylin C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):85-90. PubMed ID: 10477010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation.
    Freedman GM; Li T; Nicolaou N; Chen Y; Ma CC; Anderson PR
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):689-94. PubMed ID: 19362779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
    Pinnarò P; Soriani A; Landoni V; Giordano C; Papale M; Marsella A; Marucci L; Arcangeli G; Strigari L
    J Exp Clin Cancer Res; 2010 Jan; 29(1):9. PubMed ID: 20100335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
    Jin K; Luo J; Yu X; Guo X
    Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial.
    Livi L; Buonamici FB; Simontacchi G; Scotti V; Fambrini M; Compagnucci A; Paiar F; Scoccianti S; Pallotta S; Detti B; Agresti B; Talamonti C; Mangoni M; Bianchi S; Cataliotti L; Marrazzo L; Bucciolini M; Biti G
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):509-15. PubMed ID: 19700248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.
    Romestaing P; Lehingue Y; Carrie C; Coquard R; Montbarbon X; Ardiet JM; Mamelle N; Gérard JP
    J Clin Oncol; 1997 Mar; 15(3):963-8. PubMed ID: 9060534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Objective assessment of dermatitis following post-operative radiotherapy in patients with breast cancer treated with breast-conserving treatment.
    Yoshida K; Yamazaki H; Takenaka T; Tanaka E; Kotsuma T; Fujita Y; Masuda N; Kuriyama K; Yoshida M; Nishimura T
    Strahlenther Onkol; 2010 Nov; 186(11):621-9. PubMed ID: 21072624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy.
    Berberich W; Schnabel K; Berg D; Lamprecht E
    Eur J Obstet Gynecol Reprod Biol; 2001 Feb; 94(2):276-82. PubMed ID: 11165739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center.
    Díaz-Gavela AA; Cerro Peñalver ED; Sanchez-Garcia S; Pardo-Perez E; Thuissard-Vasallo IJ; Andreu-Vázquez C; Molina López MY; Pena Huertas M; Guerrero-Gómez LL; Sanz-Rosa D; Lorenzo FC
    Brachytherapy; 2024; 23(3):342-354. PubMed ID: 38522961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.